Compile Data Set for Download or QSAR
maximum 50k data
Found 10 with Last Name = 'shomi' and Initial = 'g'
LigandPNGBDBM160544(US9040717, Compound (3))
Affinity DataIC50:  3.5nMpH: 8.0Assay Description:For expression of hPDHK1 activity, Escherichia coli strain BL21(DE3) cells (Novagen) were transformed with the pET17b vector containing modified hPDH...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM160544(US9040717, Compound (3))
Affinity DataIC50:  4.20nMpH: 8.0 T: 2°CAssay Description:For expression of hPDHK2 activity, Escherichia coli strain BL21(DE3) cells (Novagen) were transformed with the pET17b vector containing modified hPDH...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM160542(US9040717, Compound (2) | US9040717, Compound (2h))
Affinity DataIC50:  4.60nMpH: 8.0 T: 2°CAssay Description:For expression of hPDHK2 activity, Escherichia coli strain BL21(DE3) cells (Novagen) were transformed with the pET17b vector containing modified hPDH...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM160542(US9040717, Compound (2) | US9040717, Compound (2h))
Affinity DataIC50:  4.70nMpH: 8.0Assay Description:For expression of hPDHK1 activity, Escherichia coli strain BL21(DE3) cells (Novagen) were transformed with the pET17b vector containing modified hPDH...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM160542(US9040717, Compound (2) | US9040717, Compound (2h))
Affinity DataIC50:  4.90nMpH: 8.0 T: 2°CAssay Description:For expression of hPDHK2 activity, Escherichia coli strain BL21(DE3) cells (Novagen) were transformed with the pET17b vector containing modified hPDH...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM160538(US9040717, Compound (A))
Affinity DataIC50:  5.10nMpH: 8.0 T: 2°CAssay Description:For expression of hPDHK2 activity, Escherichia coli strain BL21(DE3) cells (Novagen) were transformed with the pET17b vector containing modified hPDH...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM160541(US9040717, Compound (D))
Affinity DataIC50:  5.10nMpH: 8.0 T: 2°CAssay Description:For expression of hPDHK2 activity, Escherichia coli strain BL21(DE3) cells (Novagen) were transformed with the pET17b vector containing modified hPDH...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM160542(US9040717, Compound (2) | US9040717, Compound (2h))
Affinity DataIC50:  6.60nMpH: 8.0Assay Description:For expression of hPDHK1 activity, Escherichia coli strain BL21(DE3) cells (Novagen) were transformed with the pET17b vector containing modified hPDH...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM160540(US9040717, Compound (C))
Affinity DataIC50:  6.70nMpH: 8.0 T: 2°CAssay Description:For expression of hPDHK2 activity, Escherichia coli strain BL21(DE3) cells (Novagen) were transformed with the pET17b vector containing modified hPDH...More data for this Ligand-Target Pair
In DepthDetails US Patent
LigandPNGBDBM160539(US9040717, Compound (B))
Affinity DataIC50:  7.40nMpH: 8.0 T: 2°CAssay Description:For expression of hPDHK2 activity, Escherichia coli strain BL21(DE3) cells (Novagen) were transformed with the pET17b vector containing modified hPDH...More data for this Ligand-Target Pair
In DepthDetails US Patent